Literature DB >> 18633757

Is Ramadan fasting safe in type 2 diabetic patients in view of the lack of significant effect of fasting on clinical and biochemical parameters, blood pressure, and glycemic control?

M M'guil1, M A Ragala, L El Guessabi, S Fellat, A Chraibi, L Chabraoui, L Chebraoui, Z H Israili, B Lyoussi.   

Abstract

The study objective was to determine if Ramadan fasting was safe in patients with type 2 diabetes mellitus (T2D), based upon a determination of the effect of fasting on a broad range of physiological and clinical parameters, including markers of glycemic control and blood pressure. The study was carried out in Ramadan 1422 (December 2001-January 2002) at the Diabetology Services, Hopital Ibn Sina, Rabat, Morocco. One hundred and twenty T2D Moroccan patients (62 women, 58 men), aged 48-60 yrs with well-controlled diabetes through diet and/or oral hypoglycemic drugs (OHD), received dietary instructions and readjustment of the timing of the dose of OHD (gliclazide modified release) according to the fasting/eating periods. Anthropometric indices and physiological parameters (blood pressure, lipid, hematological, and serum electrolyte profiles, as well as markers of glycemic control, nutrition, renal and hepatic function) were measured on the day before Ramadan and then on the 15(th) and 29(th) day of fasting and thereafter 15 days later. Statistical analysis was done by standard methods. Ramadan fasting had no major effect on energy intake, body weight, body mass index, blood pressure, and liver enzymes. Fasting and post-prandial glucose levels decreased, while insulin levels increased. Diabetes was well controlled, as indicated by HbA1c, fructosamine, C-peptide, HOMA-IR, and IGF-1 values. There were fluctuations in some lipid and hematological parameters, creatinine, urea, uric acid, total protein, bilirubin, and electrolytes; however, all values stayed within the proper physiological range. In conclusion, diabetes was well-controlled in patients with dietary/medical management, without serious complications. With a regimen adjustment of OHD, diet control, and physical activity, most patients with T2D whose diabetes was well-controlled before Ramadan can safely observe Ramadan fasting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18633757     DOI: 10.1080/10641960802272442

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  16 in total

1.  Cultural influences on medicine use among first-generation Pakistani immigrants in Norway.

Authors:  Helle Håkonsen; Else-Lydia Toverud
Journal:  Eur J Clin Pharmacol       Date:  2011-08-12       Impact factor: 2.953

2.  Primary Care Providers' Knowledge and Practices of Diabetes Management During Ramadan.

Authors:  Mujtaba Ali; Alexandra Adams; Md Anwar Hossain; David Sutin; Benjamin Hyun Han
Journal:  J Prim Care Community Health       Date:  2015-08-20

3.  Importance of education in managing type 2 diabetes during Ramadan.

Authors:  Doaa Farid; Ellen Rosenberg; Gillian Bartlett
Journal:  Can Fam Physician       Date:  2014-06       Impact factor: 3.275

4.  Ramadan fasting ameliorates oxidative stress and improves glycemic control and lipid profile in diabetic patients.

Authors:  Ahmad I Al-Shafei
Journal:  Eur J Nutr       Date:  2014-01-19       Impact factor: 5.614

Review 5.  Health Benefits of Fasting and Caloric Restriction.

Authors:  Saeid Golbidi; Andreas Daiber; Bato Korac; Huige Li; M Faadiel Essop; Ismail Laher
Journal:  Curr Diab Rep       Date:  2017-10-23       Impact factor: 4.810

6.  Impact of Ramadan intermittent fasting on metabolic and inflammatory profiles in type 2 diabetic patients.

Authors:  Ibtissem Oueslati; Asma Kardi; Fatma Boukhayatia; Bassem Hammami; Meriem Cheikh; Neila Ben Romdhane; Moncef Feki; Meriem Yazidi; Melika Chihaoui
Journal:  J Diabetes Metab Disord       Date:  2022-05-07

7.  Glycemic effects of vildagliptin in patients with type 2 diabetes before, during and after the period of fasting in Ramadan.

Authors:  Line P Malha; Ghazi Taan; Mira S Zantout; Sami T Azar
Journal:  Ther Adv Endocrinol Metab       Date:  2014-02       Impact factor: 3.565

8.  Evaluating the Effect of Ramadan Fasting on Muslim Patients with Diabetes in relation to Use of Medication and Lifestyle Patterns: A Prospective Study.

Authors:  Melanie Yee Lee Siaw; Daniel Ek Kwang Chew; Rinkoo Dalan; Shaikh Abdul Kader Kamaldeen Abdul Shakoor; Noorani Othman; Chor Hui Choo; Nur Hidayah Shamsuri; Siti Nurhana Abdul Karim; Sui Yung Chan; Joyce Yu-Chia Lee
Journal:  Int J Endocrinol       Date:  2014-11-11       Impact factor: 3.257

9.  Glycemic Control among Pregnant Diabetic Women on Insulin Who Fasted During Ramadan.

Authors:  Nor Azlin Mohamed Ismail; Hadijat Olaide Raji; Norashikin Abd Wahab; Norlaila Mustafa; Nor Azmi Kamaruddin; Muhammad Abdul Jamil
Journal:  Iran J Med Sci       Date:  2011-12

10.  Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan.

Authors:  Mir Iftikhar Bashir; Md Faruque Pathan; Syed Abbas Raza; Jamal Ahmad; A K Azad Khan; Osama Ishtiaq; Rakesh K Sahay; Aisha Sheikh; Abdul Hamid Zargar
Journal:  Indian J Endocrinol Metab       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.